微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 32.17% | 11.23% | 5.2% | 108/141 | 52.4% | 佰仁医疗科技 | 88.71% | 行业排名> |
| 2026-03-31 | 30.58% | 25.06% | 4.19% | 109/141 | 52.37% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-12-31 | 29.35% | 0.34% | -4.86% | 109/141 | 51.9% | 佰仁医疗科技 | 89.18% | 行业排名> |
| 2025-09-30 | 30.85% | 4.62% | 6.65% | 110/141 | 52.23% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-06-30 | 28.92% | -4.78% | 18.28% | 113/141 | 52.48% | 佰仁医疗科技 | 88.54% | 行业排名> |
| 2025-03-31 | 24.45% | -19.11% | -16.4% | 115/141 | 52.13% | 佰仁医疗科技 | 85.72% | 行业排名> |
| 2024-12-31 | 29.25% | -16.58% | -0.81% | 112/141 | 53.08% | 佰仁医疗科技 | 88.34% | 行业排名> |
| 2024-09-30 | 29.49% | -22.06% | -2.92% | 109/141 | 53.87% | 佰仁医疗科技 | 88.56% | 行业排名> |
| 2024-06-30 | 30.37% | -21.19% | 0.47% | 111/141 | 53.95% | 佰仁医疗科技 | 89.27% | 行业排名> |
| 2024-03-31 | 30.23% | -21.38% | -13.78% | 107/141 | 53.88% | 佰仁医疗科技 | 89.28% | 行业排名> |
| 2023-12-31 | 35.06% | -10.21% | -7.32% | 105/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 37.83% | -6.76% | -1.84% | 96/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 38.54% | -8.62% | 0.23% | 98/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 38.45% | -4.54% | -1.53% | 93/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 39.05% | -15.31% | -3.76% | 101/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 40.57% | -10.95% | -3.8% | 92/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 42.17% | -6.53% | 4.71% | 91/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 40.28% | -7.64% | -12.63% | 86/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 46.1% | 10.4% | 1.19% | 91/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 45.56% | 20.72% | 0.98% | 81/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 45.12% | 22.79% | 3.46% | 88/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 43.61% | 21.74% | 4.43% | 79/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 41.76% | 26.14% | 10.65% | 107/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 37.74% | 22.25% | 2.71% | 79/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 36.75% | 13.13% | 2.58% | 98/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 35.82% | 2.43% | 8.2% | 62/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 33.11% | 7.66% | 7.24% | 102/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 30.87% | -2.12% | -4.95% | 57/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 32.48% | -2.34% | -7.13% | 63/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 34.97% | 0.93% | 13.73% | 45/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 30.75% | -11.06% | -2.5% | 99/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 31.54% | -15.51% | -5.18% | 44/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 33.26% | -14.76% | -4.01% | 48/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 34.65% | -8.85% | 0.22% | 40/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 34.57% | -17.23% | -7.38% | 84/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 37.33% | -16.6% | -4.33% | 35/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 39.02% | -9.96% | 2.64% | 43/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 38.02% | -14.6% | -8.98% | 34/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 41.77% | -5.89% | -6.69% | 57/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 44.76% | -3.85% | 3.29% | 24/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 43.34% | -8.14% | -2.65% | 30/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 44.51% | -7.71% | 0.3% | 19/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |